Search

everythinglearnresearchcommunity

for

Search:↓

Recognizing rare causes of MASLD is crucial for effective treatment and preventing complications.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

A 20-year-old woman was found to have a rare ovarian tumor causing symptoms like acne and a low-pitched voice, which disappeared after the tumor was removed.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Drinking sweetened tea and soda and poor sleep may increase the risk of hair loss in women.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

Classical PCOS types A and B are most common and linked to higher health risks.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Acne necrotica can be effectively treated with topical cream and antibiotics.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Platelet-rich plasma injections significantly improved hair regrowth and thickness in patients with hair loss.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.